RecruitingPhase 4NCT06754371

Prophylactic Tranexamic Acid Reduces Postpartum Hemorrhage

Studying Systemic autoimmune disease

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: RenJi Hospital
Principal Investigator: Jie Xiao, PHD, Psyd,LMFT,CHT
Renji Hospital, Shanghai Jiaotong University, School of Medcine
Intervention: tranexamic acid(drug)
Enrollment: 276 target
Eligibility: 18-50 years · FEMALE
Timeline: 2025 – 2027

Study locations (1)

Renji Hospital, Shanghai Jiaotong University, School of Medcine, Shanghai, Shanghai Municipality, China

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06754371 on ClinicalTrials.gov

← Back to all trials